The 7th Global NAFLD/MASLD Congress covers topics such as:
- Automated approach for diagnosis, staging and risk assessment of NASH
- Recent Updates in NASH Pathogenesis
- Advances in Therapeutics
- Updates to the Development Pipeline: Preclinical and Clinical
- How non-invasive tests may replace liver biopsy as the referent standard for the pragmatic clinical management of NAFLD
- Advances in anti-obesity medications as well as research into the efficacy of exercise as medicine for patients with NAFLD
- Pathophysiology and treatment of pediatric NAFLD
- Relationship between type 2 diabetes and NAFLD and relevant treatments for NAFLD
- NAFLD and bariatric surgery
The 7th Global NAFLD/MASLD Congress brings together attendees from:
- Industry
- Hospitals and universities
NAFLD - Nonalcoholic fatty liver disease
MASLD - Metabolic dysfunction-associated steatotic liver disease
NASH - Nonalcoholic steatohepatitis.
The 7th Global NAFLD/MASLD Congress will be held in London, United Kingdom on 24-25 Jun 2024.